Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Messer

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Muscle Research and Cell Motility|May 29, 2013
Tropomyosin isoform expression and phosphorylation in the human heart in health and diseaseSteven B Marston, O'Neal Copeland, Andrew E Messer, et al.
Biophysical Journal|November 25, 2014
The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin IPetr G Vikhorev, Weihua Song, Ross Wilkinson, et al.
Journal of Muscle Research and Cell Motility|August 14, 2010
Investigation of changes in skeletal muscle alpha-actin expression in normal and pathological human and mouse heartsO'Neal Copeland, Kristen J Nowak, Nigel G Laing, et al.
ACS Pharmacology & Translational Science|May 15, 2025
5,7-Dimethoxychroman-3-yl 4-methoxybenzoate Has a Unique Effect upon the Modulation of Mutant Cardiac Muscle Thin Filament Function and Dynamics due to Phosphorylation of Troponin IZeyu Yang, Alice M Sheehan, Mary Papadaki, et al.
Frontiers in Physiology|April 12, 2018
Molecular Defects in Cardiac Myofilament Ca<sup>2+</sup>-Regulation Due to Cardiomyopathy-Linked Mutations Can Be Reversed by Small Molecules Binding to TroponinAlice Sheehan, Andrew E Messer, Maria Papadaki, et al.
Plos One|September 26, 2015
OBSCN Mutations Associated with Dilated Cardiomyopathy and HaploinsufficiencySteven Marston, Cecile Montgiraud, Alex B Munster, et al.
Frontiers in Physiology|December 30, 2024
Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations <i>in vitro</i>, <i>in vivo</i>, and <i>in silico</i>Zeyu Yang, Alice M Sheehan, Andrew E Messer, et al.
Journal of Molecular and Cellular Cardiology|June 25, 2008
Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscleAdam M Jacques, O'Neal Copeland, Andrew E Messer, et al.
Scientific Reports|January 7, 2015
Selective and contagious prosocial resource donation in capuchin monkeys, chimpanzees and humansNicolas Claidière, Andrew Whiten, Mary C Mareno, et al.
Archives of Biochemistry and Biophysics|April 3, 2016
Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylationAndrew E Messer, Christopher R Bayliss, Mohammed El-Mezgueldi, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Muscle Research and Cell Motility|May 29, 2013
Tropomyosin isoform expression and phosphorylation in the human heart in health and diseaseSteven B Marston, O'Neal Copeland, Andrew E Messer, et al.
Biophysical Journal|November 25, 2014
The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin IPetr G Vikhorev, Weihua Song, Ross Wilkinson, et al.
Journal of Muscle Research and Cell Motility|August 14, 2010
Investigation of changes in skeletal muscle alpha-actin expression in normal and pathological human and mouse heartsO'Neal Copeland, Kristen J Nowak, Nigel G Laing, et al.
ACS Pharmacology & Translational Science|May 15, 2025
5,7-Dimethoxychroman-3-yl 4-methoxybenzoate Has a Unique Effect upon the Modulation of Mutant Cardiac Muscle Thin Filament Function and Dynamics due to Phosphorylation of Troponin IZeyu Yang, Alice M Sheehan, Mary Papadaki, et al.
Frontiers in Physiology|April 12, 2018
Molecular Defects in Cardiac Myofilament Ca<sup>2+</sup>-Regulation Due to Cardiomyopathy-Linked Mutations Can Be Reversed by Small Molecules Binding to TroponinAlice Sheehan, Andrew E Messer, Maria Papadaki, et al.
Plos One|September 26, 2015
OBSCN Mutations Associated with Dilated Cardiomyopathy and HaploinsufficiencySteven Marston, Cecile Montgiraud, Alex B Munster, et al.
Frontiers in Physiology|December 30, 2024
Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations <i>in vitro</i>, <i>in vivo</i>, and <i>in silico</i>Zeyu Yang, Alice M Sheehan, Andrew E Messer, et al.
Journal of Molecular and Cellular Cardiology|June 25, 2008
Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscleAdam M Jacques, O'Neal Copeland, Andrew E Messer, et al.
Scientific Reports|January 7, 2015
Selective and contagious prosocial resource donation in capuchin monkeys, chimpanzees and humansNicolas Claidière, Andrew Whiten, Mary C Mareno, et al.
Archives of Biochemistry and Biophysics|April 3, 2016
Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylationAndrew E Messer, Christopher R Bayliss, Mohammed El-Mezgueldi, et al.
Pageof 6